Published August 15, 2022
| Version v1
Dataset
Open
A promising target for non-hormonal contraception – The a/b Hydrolase Domain 2
Description
Summary of results in 2022 for a/b Hydrolase Domain 2 (ABHD2) in the scope of the Structural Genomics Consortium's Women’s and Children’s Health Initiative funded by the Bill & Melinda Gates Foundation for characterizing potential targets for new non-hormonal contraceptives.
Files
SGC_NHC_OA_ABHD2_AnnualReport_2022_v3.pdf
Files
(1.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:20626c2df0f54272c9cc40ac238d02ab
|
1.3 MB | Preview Download |